Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2011
Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition
Jane L Armstrong, Marco Corazzari, Shaun Martin, et al.
Cardiovascular Research
|
April 16, 2024
ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport
Bin Liu, Mujahid Azfar, Ekaterina Legchenko, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 3, 2015
A lipid switch unlocks Parkinson's disease-associated ATP13A2
Tine Holemans, Danny Mollerup Sørensen, Sarah van Veen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 24, 2020
ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress
Stephanie Vrijsen, Laura Besora-Casals, Sarah van Veen, et al.
The Journal of Biological Chemistry
|
December 14, 2020
ATP13A3 is a major component of the enigmatic mammalian polyamine transport system
Norin Nabil Hamouda, Chris Van den Haute, Roeland Vanhoutte, et al.
Cancer Research
|
March 13, 2015
Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin
Aleksandra M Dudek-Perić, Gabriela B Ferreira, Angelika Muchowicz, et al.
Scientific Reports
|
January 31, 2017
A novel approach to analyze lysosomal dysfunctions through subcellular proteomics and lipidomics: the case of NPC1 deficiency
Arun Kumar Tharkeshwar, Jesse Trekker, Wendy Vermeire, et al.
Nature
|
January 31, 2020
ATP13A2 deficiency disrupts lysosomal polyamine export
Sarah van Veen, Shaun Martin, Chris Van den Haute, et al.
Acta Neuropathologica
|
March 16, 2020
Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export
Shaun Martin, Stefanie Smolders, Chris Van den Haute, et al.
Brain : a Journal of Neurology
|
February 1, 2017
Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)
Alejandro Estrada-Cuzcano, Shaun Martin, Teodora Chamova, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2011
Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition
Jane L Armstrong, Marco Corazzari, Shaun Martin, et al.
Cardiovascular Research
|
April 16, 2024
ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport
Bin Liu, Mujahid Azfar, Ekaterina Legchenko, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 3, 2015
A lipid switch unlocks Parkinson's disease-associated ATP13A2
Tine Holemans, Danny Mollerup Sørensen, Sarah van Veen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 24, 2020
ATP13A2-mediated endo-lysosomal polyamine export counters mitochondrial oxidative stress
Stephanie Vrijsen, Laura Besora-Casals, Sarah van Veen, et al.
The Journal of Biological Chemistry
|
December 14, 2020
ATP13A3 is a major component of the enigmatic mammalian polyamine transport system
Norin Nabil Hamouda, Chris Van den Haute, Roeland Vanhoutte, et al.
Cancer Research
|
March 13, 2015
Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin
Aleksandra M Dudek-Perić, Gabriela B Ferreira, Angelika Muchowicz, et al.
Scientific Reports
|
January 31, 2017
A novel approach to analyze lysosomal dysfunctions through subcellular proteomics and lipidomics: the case of NPC1 deficiency
Arun Kumar Tharkeshwar, Jesse Trekker, Wendy Vermeire, et al.
Nature
|
January 31, 2020
ATP13A2 deficiency disrupts lysosomal polyamine export
Sarah van Veen, Shaun Martin, Chris Van den Haute, et al.
Acta Neuropathologica
|
March 16, 2020
Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export
Shaun Martin, Stefanie Smolders, Chris Van den Haute, et al.
Brain : a Journal of Neurology
|
February 1, 2017
Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)
Alejandro Estrada-Cuzcano, Shaun Martin, Teodora Chamova, et al.
Page
of 4